The DOI matches its Crossref record; 458 of the 462 references it cites were found in a registry or an index.
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Open accessAbstract
Serotonergic hallucinogens, such as (+)-lysergic acid diethylamide, psilocybin, and mescaline, are somewhat enigmatic substances. Although these drugs are derived from multiple chemical families, they all produce remarkably similar effects in animals and humans, and they show cross-tolerance. This article reviews the evidence demonstrating the serotonin 5-HT2A receptor is the primary site of hallucinogen action. The 5-HT2A receptor is responsible for mediating the effects of hallucinogens in human subjects, as well as in animal behavioral paradigms such as drug discrimination, head twitch response, prepulse inhibition of startle, exploratory behavior, and interval timing. Many recent clinical trials have yielded important new findings regarding the psychopharmacology of these substances. Furthermore, the use of modern imaging and electrophysiological techniques is beginning to help unravel how hallucinogens work in the brain. Evidence is also emerging that hallucinogens may possess therapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190 · cited 1×
“…that psilocybin reduces activity and connectivity in core nodes of the default-mode network, brain regions that are active during the resting state and potentially involved in introspective processes (for more information, see: Raichle et al., 2001; Mason et al., 2007; Buckner et al., 2008).”
BackgroundThe Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761 · cited 2×
“…that psilocybin reduces activity and connectivity in core nodes of the default-mode network, brain regions that are active during the resting state and potentially involved in introspective processes (for more information, see: Raichle et al., 2001; Mason et al., 2007; Buckner et al., 2008).”
BackgroundResultParallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“CSTC loops are parallel, anatomically segregated circuits relaying information between the basal ganglia, thalamus, and cortex (Alexander et al., 1986, 1990).”
BackgroundLeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576 · cited 2×
“Since cortical oscillations play a fundamental role in a diverse set of mental processes and are required for the coordination of neural processing (Gray et al., 1989; Singer, 1999; Buzsaki and Draguhn, 2004; Sejnowski and Paulsen, 2006; Fries, 2009; Klimesch, 2012), it is tempting to speculate that the reduction of n…”
BackgroundNeurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551 · cited 1×
“One potential explanation is that the hemodynamic responses measured by fMRI are actually better correlated with cortical oscillatory activity than with neuronal firing (Mathiesen et al., 1998; Logothetis et al., 2001; Behav Brain Res.”
BackgroundGray, C. M., König, P., Engel, A. K., & Singer, W. (1989) · Nature · doi:10.1038/338334a0 · Cited by 4,183 · cited 2×
“Since cortical oscillations play a fundamental role in a diverse set of mental processes and are required for the coordination of neural processing (Gray et al., 1989; Singer, 1999; Buzsaki and Draguhn, 2004; Sejnowski and Paulsen, 2006; Fries, 2009; Klimesch, 2012), it is tempting to speculate that the reduction of n…”
BackgroundThalamocortical oscillations in the sleeping and aroused brain
Steriade, M., McCormick, D. A., & Sejnowski, T. J. (1993) · Science · doi:10.1126/science.8235588 · Cited by 3,564 · cited 1×
“Under anesthesia or during slow-wave sleep, cortical networks display slow (0.5–1 Hz) and delta (1–4 Hz) oscillations (Steriade et al., 1993a,b; Steriade, 1997) that reflect alternations between periods of silence (DOWN states) and periods of depolarization with repetitive spiking (UP states).”
BackgroundInfluentialAlpha-band oscillations, attention, and controlled access to stored information
Klimesch, W. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.10.007 · Cited by 3,310 · cited 2×
“Since cortical oscillations play a fundamental role in a diverse set of mental processes and are required for the coordination of neural processing (Gray et al., 1989; Singer, 1999; Buzsaki and Draguhn, 2004; Sejnowski and Paulsen, 2006; Fries, 2009; Klimesch, 2012), it is tempting to speculate that the reduction of n…”
BackgroundInternational Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025 · cited 2×
“The 5-HT2 receptor class was later reorganized to include three subtypes: 5-HT2A (equivalent to the site known historically as the 5-HT2 receptor or the D receptor), 5-HT2B (formerly known as the 5HT2F receptor), and 5-HT2C (formerly known as the 5-HT1C receptor) (Hoyer et al., 1994).”
BackgroundMechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796 · cited 1×
“GABAergic interneurons expressing parvalbumin and calbindin are sources of perisomatic inhibition that synchronize the oscillatory firing of large ensembles of pyramidal neurons (Bartos et al., 2007; Freund and Katona, 2007; Buzsaki and Wang, 2012).”
BackgroundWandering minds: the default network and stimulus-independent thought
Mason, M. F., Norton, M. I., Van Horn, J. D., Wegner, D. M., Grafton, S. T., & Macrae, C. N. (2007) · Science · doi:10.1126/science.1131295 · Cited by 2,792 · cited 2×
“…that psilocybin reduces activity and connectivity in core nodes of the default-mode network, brain regions that are active during the resting state and potentially involved in introspective processes (for more information, see: Raichle et al., 2001; Mason et al., 2007; Buckner et al., 2008).”
BackgroundResultModulation of Oscillatory Neuronal Synchronization by Selective Visual Attention
Fries, P., Reynolds, J. H., Rorie, A. E., & Desimone, R. (2001) · Science · doi:10.1126/science.1055465 · Cited by 2,786 · cited 2×
“…the active waking state, which is characterized by fast rhythms in the gamma range (30–80 Hz) that play a putative role in a multitude of perceptual and cognitive functions (Tallon-Baudry et al., 1998; Fries et al., 2001; Herrmann et al., 2004; Schroeder and Lakatos, 2009; Roux and Uhlhaas, 2014).”
BackgroundNeuronal Synchrony: A Versatile Code for the Definition of Relations?
Singer, W. (1999) · Neuron · doi:10.1016/s0896-6273(00)80821-1 · Cited by 2,581 · cited 2×
“Since cortical oscillations play a fundamental role in a diverse set of mental processes and are required for the coordination of neural processing (Gray et al., 1989; Singer, 1999; Buzsaki and Draguhn, 2004; Sejnowski and Paulsen, 2006; Fries, 2009; Klimesch, 2012), it is tempting to speculate that the reduction of n…”
BackgroundAlexander, G. E., Crutcher, M. D., & DeLong, M. R. (1990) · PubMed · Cited by 2,422
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120 · cited 2×
“…that schizophrenia patients show deficits of gamma oscillations and synchrony (Spencer et al., 2003; Cho et al., 2006; Minzenberg et al., 2010; Uhlhaas and Singer, 2010) and reductions in slow-wave sleep (Yang and Winkelman, 2006), and it has been hypothesized that these abnormalities play an…”
BackgroundSynaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070 · cited 1×
“GABAergic interneurons expressing parvalbumin and calbindin are sources of perisomatic inhibition that synchronize the oscillatory firing of large ensembles of pyramidal neurons (Bartos et al., 2007; Freund and Katona, 2007; Buzsaki and Wang, 2012).”
Background(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62678-3 · Cited by 1,961 · cited 1×
“CSTC loops are parallel, anatomically segregated circuits relaying information between the basal ganglia, thalamus, and cortex (Alexander et al., 1986, 1990).”
BackgroundSteriade, M., Nunez, A., & Amzica, F. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03252.1993 · Cited by 1,903 · cited 1×
“Under anesthesia or during slow-wave sleep, cortical networks display slow (0.5–1 Hz) and delta (1–4 Hz) oscillations (Steriade et al., 1993a,b; Steriade, 1997) that reflect alternations between periods of silence (DOWN states) and periods of depolarization with repetitive spiking (UP states).”
BackgroundInfluentialNeuronal gamma-band synchronization as a fundamental process in cortical computation
Fries, P. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135603 · Cited by 1,713 · cited 2×
“Since cortical oscillations play a fundamental role in a diverse set of mental processes and are required for the coordination of neural processing (Gray et al., 1989; Singer, 1999; Buzsaki and Draguhn, 2004; Sejnowski and Paulsen, 2006; Fries, 2009; Klimesch, 2012), it is tempting to speculate that the reduction of n…”
BackgroundGriffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 5×
“Another notable difference between ketamine and serotonergic hallucinogens is that ketamine does not produce mystical experiences (Lofwall et al., 2006), whereas hallucinogens induce these states with some reliability (Pahnke, 1969; Griffiths et al., 2006, 2008, 2011; Lyvers and Meester, 2012).”
BackgroundInfluentialPredicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · cited 1×
“…do not produce head twitches in response to mescaline, DOI, DOM, LSD, DMT, 5-MeO-DMT, psilocin, or 1-methylpsilocin (González-Maeso et al., 2007; Keiser et al., 2009; Halberstadt et al., 2011), although the response can be rescued by selectively restoring the 5-HT2A receptor gene to cortical…”
BackgroundSesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902900205 · Cited by 1,568 · cited 1×
“The LC also receives excitatory input from the prefrontal cortex (PFC), both directly and indirectly (Sesack et al., 1989; Jodo and Aston-Jones, 1997; Jodo et al., 1998), and the excitatory effects of hallucinogens on the LC may be mediated by those pathways.”
BackgroundPeroutka, S. J., & Snyder, S. H. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13812-1 · Cited by 1,363 · cited 1×
“After introduction of the dopamine antagonist radioligand [3H]spiperone, it was recognized that [3H]spiperone binds to 5-HT receptors distinct from the sites labeled by [3H]5-HT (Peroutka and Snyder, 1979).”
BackgroundProposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,259 · cited 1×
“The D receptor was eventually shown to be equivalent to the 5-HT2 receptor, whereas the M receptor is pharmacologically distinct from 5-HT1 sites and was later classified by Bradley and coworkers (Bradley et al., 1986) as the 5-HT3 receptor.”
BackgroundPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 5×
“The values reported by Grob et al. (2011) were reanalyzed using the 11 new homogenous APZ subscales developed by Studerus et al. (2010).”
BackgroundMethodInfluentialSelf-citationNeural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 2×
“Likewise, hallucinogens enhance memory recall (Carhart-Harris et al., 2012b), sometimes producing extremely vivid recollections.”
BackgroundFunctional connectivity of human striatum: a resting state FMRI study
Di Martino, A., Scheres, A., Margulies, D. S., Kelly, A. M. C., Uddin, L. Q., Shehzad, Z., Biswal, B., Walters, J. R., Castellanos, F. X., & Milham, M. P. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn041 · Cited by 1,090 · cited 1×
“There has been some debate about the exact number of CSTC loops (Middleton and Strick, 2001; Di Martino et al., 2008), but at least five have been putatively identified, each serving a different function.”
BackgroundLeysen, J. E., Niemegeers, C. J. E., Nueten, J. M. V., & Laduron, P. M. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14623-3 · Cited by 1,071 · cited 1×
“It was proposed in 1982 that the mescaline-induced HTR is mediated by the 5- HT2A receptor, based on the fact that the relative potency of 5-HT antagonists to block the behavior is correlated (r = 0.875) with their 5-HT2A affinity (Leysen et al., 1982).”
BackgroundInfluentialSwerdlow, N. R., Geyer, M. A., & BRAFF, D. L. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,053 · cited 1×
“Importantly, PPI is regulated by components of the limbic CSTC loop, including mPFC, NAc, and VP (Swerdlow et al., 2001).”
BackgroundHallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035 · cited 1×
“Among patients with Parkinson's disease, approximately 22% experience complex visual hallucinations (Fenelon et al., 2000).”
BackgroundPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 7×
“The excitation of V1 is presumably driven by 5- HT2A receptors because ketanserin blocks the visual hallucinations induced by psilocybin (Vollenweider et al., 1998; Kometer et al., 2013).”
BackgroundInfluentialRegulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · cited 1×
“Since 5-HT2C editing can influence the downstream coupling of the receptor (Burns et al., 1997), the nature of the interactions between 5-HT2A and 5-HT2C could potentially vary by mouse strain.”
BackgroundPrefrontal and medial temporal lobe interactions in long-term memory
Simons, J. S., & Spiers, H. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1178 · Cited by 961 · cited 1×
“The PFC exerts top-down executive control over processing in temporal and parietal cortices (Tomita et al., 1999; Simons and Spiers, 2003; Merchant et al., 2011; Crowe et al., 2013).”
BackgroundCummings, J. L., Isaacson, S., Mills, R., Williams, H., Chi‐Burris, K., Corbett, A., Dhall, R., & Ballard, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62106-6 · Cited by 954 · cited 1×
“Two clinical trials have shown that the selective 5-HT2A inverse agonist pimavanserin reduces the severity of hallucinations in Parkinson's disease (Meltzer et al., 2010; Cummings et al., 2014).”
BackgroundPsilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932 · cited 1×
“Another notable difference between ketamine and serotonergic hallucinogens is that ketamine does not produce mystical experiences (Lofwall et al., 2006), whereas hallucinogens induce these states with some reliability (Pahnke, 1969; Griffiths et al., 2006, 2008, 2011; Lyvers and Meester, 2012).”
BackgroundQuirk, G. J., Likhtik, E., Pelletier, J. G., & Paré, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08800.2003 · Cited by 927 · cited 1×
“The IL subregion of mPFC impairs fear conditioning by inhibiting central amygdaloid nucleus output neurons, which project to brainstem and hypothalamic sites responsible for expressing fear responses (Quirk et al., 2003).”
BackgroundGonzález-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · cited 11×
“Abbreviations: AA, arachidonic acid; 2-AG, 2-arachidonoylglycerol; ARF, ADP-ribosylation factor-1; DAG, diacylglycerol; DGL, diacylglycerol lipase; ERK1/2, extracellular-regulated kinases 1 and 2; GRB, growth factor receptor-bound protein 2; IP3, inositol triphosphate; p38 MAPK, p38 mitogenactivated protein kinase; ME…”
BackgroundInfluentialRoux, F., & Uhlhaas, P. J. (2013) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.10.010 · Cited by 906 · cited 1×
“…the active waking state, which is characterized by fast rhythms in the gamma range (30–80 Hz) that play a putative role in a multitude of perceptual and cognitive functions (Tallon-Baudry et al., 1998; Fries et al., 2001; Herrmann et al., 2004; Schroeder and Lakatos, 2009; Roux and Uhlhaas, 2014).”
BackgroundGriffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905 · cited 3×
“Psilocybin can induce highly meaningful spiritual experiences (Griffiths et al., 2006), and some subjects have reported experiencing positive changes in mood and behavior that persist for many months (Griffiths et al., 2008).”
BackgroundInduced γ-Band Activity during the Delay of a Visual Short-Term Memory Task in Humans
Tallon‐Baudry, C., Bertrand, O., Peronnet, F., & Pernier, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04244.1998 · Cited by 900 · cited 1×
“…the active waking state, which is characterized by fast rhythms in the gamma range (30–80 Hz) that play a putative role in a multitude of perceptual and cognitive functions (Tallon-Baudry et al., 1998; Fries et al., 2001; Herrmann et al., 2004; Schroeder and Lakatos, 2009; Roux and Uhlhaas, 2014).”
BackgroundTWO KINDS OF TRYPTAMINE RECEPTOR
Gaddum, J. H., & Picarelli, Z. P. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00142.x · Cited by 851
Hemodynamic Signals Correlate Tightly with Synchronized Gamma Oscillations
Niessing, J., Ebisch, B., Schmidt, K. E., Niessing, M., Singer, W., & Galuske, R. A. W. (2005) · Science · doi:10.1126/science.1110948 · Cited by 806 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Niessing et al., 2005; Nir et al., 2007; Viswanathan and Freeman, 2007).”
BackgroundIdentification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803 · cited 1×
“Evidence has emerged that mGlu2 and 5- HT2A receptors can form heteromeric complexes in cortex (Gonzalez-Maeso et al., 2008; Moreno et al., 2012), and these complexes may mediate the crosstalk that occurs between these receptors.”
BackgroundCognitive functions of gamma-band activity: memory match and utilization
Herrmann, C. S., Munk, M. H. J., & Engel, A. K. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.06.006 · Cited by 755 · cited 2×
“…the active waking state, which is characterized by fast rhythms in the gamma range (30–80 Hz) that play a putative role in a multitude of perceptual and cognitive functions (Tallon-Baudry et al., 1998; Fries et al., 2001; Herrmann et al., 2004; Schroeder and Lakatos, 2009; Roux and Uhlhaas, 2014).”
BackgroundGasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750 · cited 1×
“Recent clinical trials have investigated whether psilocybin has efficacy against anxiety in terminal cancer patients (Grob et al., 2011), and LSD has been tested as a potential adjunct for psychotherapy (Gasser et al., 2014).”
BackgroundSchoepp, D. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 693 · cited 1×
“…and it is possible the crosstalk is purely functional and occurs at the circuit level. mGlu2 receptors function predominantly as presynaptic autoreceptors (Schoepp, 2001), so mGlu2 activation could potentially suppress 5-HT2Ainduced spontaneous EPSCs by reducing Glu release from axon terminals.”
BackgroundSerotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, Á., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 684
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683 · cited 3×
“Vollenweider and colleagues have conducted a psychometric assessment of APZ-OAV data pooled from 43 studies with psilocybin, (S)-ketamine, and the entactogen 3,4methylenedioxymethamphetamine (MDMA, “Ecstasy”) (Studerus et al., 2010).”
MethodShulgin, A. T., & Shulgin, A. (1991) · Cited by 668
Freund, T. F., & Katona, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.012 · Cited by 656
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651 · cited 2×
“, 2009) and the trace amine receptor (Bunzow et al., 2001), and are substrates for the 5-HT transporter (SERT) (Nagai et al.”
BackgroundEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & MCKENNEY, J. D. J. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 635 · cited 4×
“Additionally, there is a very strong correlation (r = 0.90–0.97) between 5- HT2A receptor affinity and human hallucinogenic potency (Glennon et al., 1984; Titeler et al., 1988; Sadzot et al., 1989).”
BackgroundMethodInfluentialSwerdlow, N. R., & Geyer, M. A. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033326 · Cited by 626 · cited 1×
“…phenomenon where a weak prestimulus presented prior to a startling stimulus will attenuate the startle response; PPI is often used as an operational measure of sensorimotor gating, and reflects central mechanisms that filter out irrelevant or distracting sensory stimuli (Swerdlow and Geyer, 1998).”
BackgroundAbnormal neural synchrony in schizophrenia
Spencer, K. M., Nestor, P. G., Niznikiewicz, M. A., Salisbury, D. F., Shenton, M. E., & McCarley, R. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07407.2003 · Cited by 624 · cited 2×
“Along these lines, there is evidence that schizophrenia patients show deficits of gamma oscillations and synchrony (Spencer et al., 2003; Cho et al., 2006; Minzenberg et al., 2010; Uhlhaas and Singer, 2010) and reductions in slow-wave sleep (Yang and Winkelman, 2006), and it has been hypothesized that these abnormalit…”
BackgroundAraneda, R. C., & Andrade, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90128-b · Cited by 621 · cited 2×
“…neurons: there is a moderate depolarization, spike-frequency accommodation is reduced, and the afterhyperpolarization (AHP) that normally follows a burst of spikes is replaced by a slow depolarizing afterpotential (sADP)(Araneda and Andrade, 1991; Tanaka and North, 1993; Arvanov et al., 1999).”
Nir, Y., Fisch, L., Mukamel, R., Gelbard-Sagiv, H., Arieli, A., Fried, I., & Malach, R. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.066 · Cited by 621 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Niessing et al., 2005; Nir et al., 2007; Viswanathan and Freeman, 2007).”
BackgroundTop-down signal from prefrontal cortex in executive control of memory retrieval
Tomita, H., Ohbayashi, M., Nakahara, K., Hasegawa, I., & Miyashita, Y. (1999) · Nature · doi:10.1038/44372 · Cited by 615 · cited 1×
“The PFC exerts top-down executive control over processing in temporal and parietal cortices (Tomita et al., 1999; Simons and Spiers, 2003; Merchant et al., 2011; Crowe et al., 2013).”
BackgroundA mathematical theory of visual hallucination patterns
Ermentrout, B., & Cowan, J. D. (1979) · Biological Cybernetics · doi:10.1007/bf00336965 · Cited by 594 · cited 1×
“Several theoretical explanations for geometric visual hallucinations have been proposed based on retinocortical mapping and the architecture of V1 (Ermentrout and Cowan, 1979; Behav Brain Res.”
Impairments in frontal cortical γ synchrony and cognitive control in schizophrenia
CHO, R. Y., Konecky, R. O., & Carter, C. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609440103 · Cited by 586 · cited 1×
“Along these lines, there is evidence that schizophrenia patients show deficits of gamma oscillations and synchrony (Spencer et al., 2003; Cho et al., 2006; Minzenberg et al., 2010; Uhlhaas and Singer, 2010) and reductions in slow-wave sleep (Yang and Winkelman, 2006), and it has been hypothesized…”
BackgroundThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577 · cited 13×
“The values reported by Grob et al. (2011) were reanalyzed using the 11 new homogenous APZ subscales developed by Studerus et al. (2010).”
BackgroundInfluentialJakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536 · cited 2×
“Almost all prefrontal pyramidal neurons express the 5-HT2A receptor, with the receptor localized primarily to the proximal apical dendrites (Willins et al., 1997; Jakab and Goldman-Rakic, 1998; Cornea-Hébert et al., 1999; Xu and Pandey, 2000).”
BackgroundThe Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · cited 2×
“Certain indolealkylamines, most notably DMT and some of its derivatives, bind to σ1 receptors (Fontanilla et al., 2009) and the trace amine receptor (Bunzow et al., 2001), and are substrates for the 5-HT transporter (SERT) (Nagai et al., 2007; Cozzi et al., 2009).”
BackgroundAghajanian, G. K., & Marek, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 516 · cited 20×
“The 5- HT1A antagonist WAY-100635 does not alter LSD discrimination in rats (Appel et al., 2004; Reissig et al., 2005; Gresch et al., 2007), but the 5-HT1A receptor may make an more prominent contribution to the LSD cue in mice because discrimination can be partially blocked by administration of either WAY-100635 or M…”
BackgroundInfluentialBennett, J. P., & Snyder, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10753-0 · Cited by 509
The anatomy of conscious vision: an fMRI study of visual hallucinations
Ffytche, D. H., Howard, R. J., Brammer, M. J., David, A. S., Woodruff, P. W. R., & Williams, S. (1998) · Nature Neuroscience · doi:10.1038/3738 · Cited by 504 · cited 1×
“There is evidence that excitation of Brodmann area (BA) 19 and BA 37 can produce complex visual hallucinations (Ffytche et al., 1998; Holroyd and Wooten, 2006; Kazui et al., 2009).”
BackgroundBroadband Cortical Desynchronization Underlies the Human Psychedelic State
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2063-13.2013 · Cited by 499 · cited 2×
“) produces broadband reductions in cortical oscillatory power (Muthukumaraswamy et al., 2013).”
BackgroundSantana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486 · cited 2×
“Likewise, in rats, a large percentage of the cells in the superficial, middle, and deep layers of the secondary motor, anterior cingulate (ACA), prelimbic (PrL), and infralimbic (IL) areas express 5-HT2A mRNA (Amargos-Bosch et al., 2004; Santana et al., 2004).”
BackgroundMillan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J. A., & Newman‐Tancredi, A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039867 · Cited by 485 · cited 1×
“6), and acts as an agonist at a variety of serotonergic, dopaminergic, and adrenergic receptors (Leysen, 1989; Piercey et al,. 1996; Egan et al., 1998; Marona-Lewicka et al., 2002; Millan et al., 2002; Nichols et al., 2002).”
BackgroundAmygdala intercalated neurons are required for expression of fear extinction
Likhtik, E., Popa, D., Apergis-Schoute, J., Fidacaro, G. A., & Paré, D. (2008) · Nature · doi:10.1038/nature07167 · Cited by 474 · cited 2×
“…mPFC inhibits the amygdala because the projection is glutamatergic (Amaral and Insausti, 1992; Smith et al., 2000), the mechanism is now believed to involve excitation of GABAergic neurons in the intercalated nuclei of the amygdala (Berretta et al., 2005; Likhtik et al., 2008; Pinard et al., 2012).”
BackgroundInhibitory Stabilization of the Cortical Network Underlies Visual Surround Suppression
Ozeki, H., Finn, I. M., Schaffer, E., Miller, K. D., & Ferster, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.028 · Cited by 470 · cited 1×
“Visual input stabilizes network activity in V1 by driving inhibitory interneurons (Ozeki et al., 2009).”
BackgroundStrassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · cited 2×
“Another instrument is the Hallucinogen Rating Scale (HRS), which was specifically designed to measure the effects of parenteral DMT (Strassman et al., 1994) Double-blind studies have confirmed the APZ and the HRS can distinguish the effects of psilocybin and mescaline from those of…”
BackgroundMethodInferior Temporal Cortex: Where Visual Perception Meets Memory
Miyashita, Y. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001333 · Cited by 452
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444 · cited 10×
“In contrast to those findings, another group has reported that higher doses of DOI (3–5 mg/kg, i.p.) tend to inhibit the firing of pyramidal cells in ACA and the ventral, dorsolateral, and lateral orbitofrontal cortices of behaving rats (Wood et al., 2012).”
BackgroundInfluentialMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Halberstadt, A. L., & Geyer, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.017 · Cited by 435 · cited 4×
“LSD and other ergoline hallucinogens display high affinity for 5- HT receptors, as well as dopaminergic and adrenergic receptors (reviewed by: Halberstadt and Geyer, 2011; Nichols, 2012).”
BackgroundInfluentialSelf-citationCortical 5-HT 2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice
Weisstaub, N., Zhou, M., Lira, A., Lambe, E. K., González‐Maeso, J., Hornung, J., Sibille, E. L., Underwood, M. D., Itohara, S., Dauer, W. T., et al. (2006) · Science · doi:10.1126/science.1123432 · Cited by 434 · cited 1×
“However, although the ability of 5-HT to induce EPSCs is lost after deletion of the 5-HT2A gene (htr2A−/− mice), the effect can be rescued by selective restoration of 5-HT2A receptors to pyramidal neurons in the forebrain (Weisstaub et al., 2006).”
BackgroundSteriade, M. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.6.583 · Cited by 429 · cited 2×
“Under anesthesia or during slow-wave sleep, cortical networks display slow (0.5–1 Hz) and delta (1–4 Hz) oscillations (Steriade et al., 1993a,b; Steriade, 1997) that reflect alternations between periods of silence (DOWN states) and periods of depolarization with repetitive spiking (UP states).”
BackgroundInfluentialBressloff, P. C., Cowan, J. D., Golubitsky, M., Thomas, P. J., & Wiener, M. C. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0769 · Cited by 420
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398 · cited 2×
“It is also a component of ayahuasca, an infusion or decoction prepared from DMT-containing plants in combination with species of Banisteriopsis containing β-carboline alkaloids that act as monoamine oxidase inhibitors (McKenna et al., 1984).”
BackgroundNeurometabolic coupling in cerebral cortex reflects synaptic more than spiking activity
Viswanathan, A., & Freeman, R. D. (2007) · Nature Neuroscience · doi:10.1038/nn1977 · Cited by 397 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Niessing et al., 2005; Nir et al., 2007; Viswanathan and Freeman, 2007).”
BackgroundA METHOD FOR ASSESSING THE EFFECTS OF DRUGS ON THE CENTRAL ACTIONS OF 5‐HYDROXYTRYPTAMINE
CORNE, S. J., Pickering, R. W., & WARNER, B. T. (1963) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1963.tb01302.x · Cited by 383 · cited 2×
“, fenfluramine and p-chloroamphetamine), and therefore the behavior is not specific to hallucinogens (Corne et al., 1963; Matthews and Smith, 1980; Singleton and Marsden, 1981; Yamaguchi et al., 1987).”
BackgroundMathiesen, C., Caesar, K., Akgören, N., & Lauritzen, M. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.555be.x · Cited by 375 · cited 1×
“One potential explanation is that the hemodynamic responses measured by fMRI are actually better correlated with cortical oscillatory activity than with neuronal firing (Mathiesen et al., 1998; Logothetis et al., 2001; Behav Brain Res.”
BackgroundAmargos-Bosch, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg128 · Cited by 370 · cited 1×
“Likewise, in rats, a large percentage of the cells in the superficial, middle, and deep layers of the secondary motor, anterior cingulate (ACA), prelimbic (PrL), and infralimbic (IL) areas express 5-HT2A mRNA (Amargos-Bosch et al., 2004; Santana et al., 2004).”
BackgroundA REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS
Osmond, H. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40738.x · Cited by 369 · cited 1×
“The exact nature of the experience is highly variable and depends on the mood and expectations of the subject (the “set”) as well as the environment in which the drug is ingested (the “setting”) (Bercel et al., 1955; Osmond, 1957; Faillace and Szára, 1968; Freedman, 1968).”
BackgroundKehne, J. H., Baron, B. M., Carr, A. A., Chaney, S., Elands, J., Feldman, D. J., Frank, R. A., van Giersbergen, P. L. M., McCloskey, T. C., Johnson, M., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12956-x · Cited by 359
Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355 · cited 6×
“The excitation of V1 is presumably driven by 5- HT2A receptors because ketanserin blocks the visual hallucinations induced by psilocybin (Vollenweider et al., 1998; Kometer et al., 2013).”
BackgroundMethodInfluentialSerotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors
Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90327-7 · Cited by 355 · cited 4×
“Moreover, 5-HT2A receptors are expressed at high to moderate densities in temporal and parietal cortical areas (Pazos et al., 1987; Lidow et al., 1989; Gross-Isseroff et al., 1990a,b; Hall et al., 2000), so the influence exerted by the PFC would act in concert with any local response induced by…”
BackgroundInfluentialTiteler, M., Lyon, R. A., & Glennon, R. A. (1988) · Psychopharmacology · doi:10.1007/bf00176847 · Cited by 343 · cited 4×
“Additionally, there is a very strong correlation (r = 0.90–0.97) between 5- HT2A receptor affinity and human hallucinogenic potency (Glennon et al., 1984; Titeler et al., 1988; Sadzot et al., 1989).”
BackgroundInfluentialThe representation of egocentric space in the posterior parietal cortex
Stein, J. F. (1992) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00072605 · Cited by 340 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript is part of the dorsal visual stream and generates multiple egocentric representations of space (Stein, 1992; Vallar et al., 1999; Schindler and Bartels, 2013).”
BackgroundA systems model of altered consciousness: integrating natural and drug-induced psychoses
Vollenweider, F. X., & Geyer, M. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00646-3 · Cited by 339 · cited 3×
“It has been theorized that hallucinogen-induced altered states may arise in part through effects on cortico-striato-thalamo-cortical (CSTC) feedback loops (Vollenweider, 1994, 1998; Vollenweider and Geyer, 2001).”
BackgroundBédard, P. J., & PYCOCK, C. (1977) · Neuropharmacology · doi:10.1016/0028-3908(77)90117-4 · Cited by 338 · cited 1×
“Hallucinogens also induce head twitches in rats, but in that species the behavior often involves both the head and the trunk (Yamamoto and Ueki, 1975; Bedard and Pycock, 1977).”
BackgroundMartín‐Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 338 · cited 1×
“For example, DOI activates serotonergic neurons in the dorsal raphe nucleus indirectly by exciting the projection from mPFC (Martín-Ruiz et al., 2001; Puig et al., 2003).”
BackgroundPollak, P. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029868 · Cited by 331 · cited 1×
“The atypical antipsychotics clozapine and risperidone, which block the 5-HT2A receptor, are also effective against the visual hallucinations (Kahn et al., 1991; Meco et al., 1997; Pollak et al., 2004).”
BackgroundKraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.010 · Cited by 323 · cited 2×
“An fMRI BOLD study in healthy volunteers revealed that psilocybin (0.16 mg/kg p.o.) reduces activation of the amygdala by negative and neutral pictures, and the BOLD signal change was inversely correlated with reports of increased positive mood (Kraehenmann et al., 2014).”
BackgroundInfluentialPotent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons
Jodoj, E., Chiang, C., & Aston-Jones, G. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00372-2 · Cited by 321
The Physiological Role of 5-HT2AReceptors in Working Memory
Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311
Realms of the Human Unconscious: Observations from LSD Research
McLaughlin, S. C., & Grof, S. (1976) · Journal for the Scientific Study of Religion · doi:10.2307/1385643 · Cited by 311 · cited 1×
“Although hallucinogens act in a relatively unspecific manner (Grof, 1980), and hence a broad range of experiences are possible, previous clinical studies have confirmed that there is also a great deal of similarity between the effects of different hallucinogens.”
BackgroundSerotonergic modulation of neurotransmission in the rat basolateral amygdala.
Rainnie, D. G. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.1.69 · Cited by 311 · cited 1×
“…and inhibitory neurons in the amygdala express 5-HT2A receptors (McDonald and Mascagni, 2007; Bombardi, 2011), and DOI and other 5-HT2A agonists act locally to produce direct excitatory and indirect inhibitory effects in the amygdala (Rainnie, 1999; Stein et al., 2000; Sokal et al., 2005).”
BackgroundSchreiber, R., Brocco, M., Audinot, V., Gobert, A., Veiga, S., & Millan, M. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09485-6 · Cited by 300 · cited 5×
“…1 DOI-induced head twitch response 1 5-HT2A antagonist ↓ M100907 Aghajanian & Marek, 1997 Beique et al., 2007 Benneyworth et al., 2007 ↓ M100907 Schreiber et al., 1995 5-HT2C antagonist Ø SB242084 Marek & Aghajanian, 1999 Beique et al., 2007 Ø SB242084 Vickers et al., 2001 Fantegrossi et…”
BackgroundResultInfluentialKometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., & Vollenweider, F. X. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.005 · Cited by 298 · cited 3×
“…(Vollenweider et al., 1998), prepulse inhibition of acoustic startle (Quednow et al., 2012), N170 visual-evoked potentials (Kometer et al., 2013), semantic interference in the Stroop test (Quednow et al., 2012), and recognition of emotional facial cues in a go/nogo task (Kometer et al., 2012).”
BackgroundMethodMeltzer, H. Y., Mills, R., Revell, S., Williams, H., Johnson, A. D., Bahr, D., & Friedman, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.176 · Cited by 293 · cited 1×
“Two clinical trials have shown that the selective 5-HT2A inverse agonist pimavanserin reduces the severity of hallucinations in Parkinson's disease (Meltzer et al., 2010; Cummings et al., 2014).”
BackgroundWhat Geometric Visual Hallucinations Tell Us about the Visual Cortex
Bressloff, P. C., Cowan, J. D., Golubitsky, M., Thomas, P. J., & Wiener, M. C. (2002) · Neural Computation · doi:10.1162/089976602317250861 · Cited by 290 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Tass, 1997; Bressloff et al., 2001, 2002; Baker and Cowan, 2009).”
BackgroundGazzaley, A., Rissman, J., Cooney, J., Rutman, A., Seibert, T., Clapp, W., & D'Esposito, M. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm113 · Cited by 287
Network Oscillations: Emerging Computational Principles
Sejnowski, T. J., & Paulsen, O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3737-05d.2006 · Cited by 284 · cited 2×
“Since cortical oscillations play a fundamental role in a diverse set of mental processes and are required for the coordination of neural processing (Gray et al., 1989; Singer, 1999; Buzsaki and Draguhn, 2004; Sejnowski and Paulsen, 2006; Fries, 2009; Klimesch, 2012), it is tempting to speculate that the reduction of n…”
BackgroundMarek, G. J., Wright, R. A., Schoepp, D. D., Monn, J. A., & Aghajanian, G. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35262-0 · Cited by 280 · cited 23×
“[PubMed: 23135605] Marek GJ. Behavioral evidence for mu-opioid and 5-HT2A receptor interactions.”
BackgroundInfluentialThe effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain
Nagai, F., Nonaka, R., & Satoh Hisashi Kamimura, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.075 · Cited by 279 · cited 3×
“However, compared with σ1 and SERT, tryptamines are more potent at 5-HT1A and 5-HT2A receptors by several orders of magnitude, so the former sites probably do not contribute to the hallucinogenic response.”
BackgroundA possible correlation between drug-induced hallucinations in man and a behavioural response in mice
CORNE, S. J., & Pickering, R. W. (1967) · Psychopharmacology · doi:10.1007/bf00401509 · Cited by 271
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Ballanger, B., Strafella, A. P., van Eimeren, T., Zurowski, M., Rusjan, P. M., Houle, S., & Fox, S. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.35 · Cited by 266 · cited 3×
“…example, a PET imaging study with [18F]setoperone found that visual hallucinations in Parkinson's patients are associated with unusually high levels of 5-HT2A binding in the inferooccipital gyrus (BA 19), fusiform gyrus (BA 20 and BA 37), and inferotemporal gyrus (BA 20) (Ballanger et al., 2010).”
BackgroundEffects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3579-0 · Cited by 266 · cited 1×
“Psilocybin and TCB-2 have been shown to facilitate the extinction of fear conditioning in C57BL/6J mice (Catlow et al., 2013; Zhang et al., 2013), which could be a consequence of activating the projection from IL to the intercalated nuclei.”
BackgroundPsychedelic Drugs Reconsidered
Seelye, E. E. (1980) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1980.34.4.593 · Cited by 257
Effects of psilocybin on time perception and temporal control of behaviour in humans
Wittmann, M., Carter, O. L., Hasler, F., Cahn, B. R., Grimberg, U., Spring, P., Hell, D., Flohr, H., & Vollenweider, F. X. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106065859 · Cited by 253 · cited 1×
“Psilocybin also alters performance on laboratory measures of timing (Wittmann et al., 2007).”
BackgroundSteininger, T. L., Gong, H., McGinty, D., & Szymusiak, R. S. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20010122)429:4 · Cited by 251
Minzenberg, M. J., Firl, A. J., Yoon, J. H., Gomes, G. C., Reinking, C., & Carter, C. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.150 · Cited by 247 · cited 2×
“…lines, there is evidence that schizophrenia patients show deficits of gamma oscillations and synchrony (Spencer et al., 2003; Cho et al., 2006; Minzenberg et al., 2010; Uhlhaas and Singer, 2010) and reductions in slow-wave sleep (Yang and Winkelman, 2006), and it has been hypothesized that…”
BackgroundWillins, D. L., & Meltzer, H. Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36840-5 · Cited by 244 · cited 1×
“These interactions have been demonstrated most extensively for the HTR (see Table 3), a 5-HT2A-mediated behavior that can be provoked by infusion of DOI directly into the mPFC (Willins and Meltzer, 1997; Ciccocioppo et al., 1999).”
BackgroundHandbook of the Behavioral Neurobiology of Serotonin
(2010) · Handbook of behavioral neuroscience · doi:10.1016/c2009-0-01827-3 · Cited by 243
Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani, N. A., Martin, B. R., Pandey, U., & Glennon, R. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90098-3 · Cited by 243 · cited 1×
“Mice show a similar behavior, known as the head twitch response (HTR), after administration of hallucinogens (Corne and Pickering, 1967;Silva and Calil, 1975; Darmani et al., 1990).”
BackgroundA fronto-parietal system for computing the egocentric spatial frame of reference in humans
Vallar, G., Löbel, E., Galati, G., Berthoz, A., Pizzamiglio, L., & Bihan, D. L. (1999) · Experimental Brain Research · doi:10.1007/s002210050624 · Cited by 241 · cited 2×
“is part of the dorsal visual stream and generates multiple egocentric representations of space (Stein, 1992; Vallar et al., 1999; Schindler and Bartels, 2013).”
BackgroundIncreased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I., & Barbanoj, M. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0358-7 · Cited by 241 · cited 1×
“Similar patterns of brain activation were found in subjects administered ayahuasca as part of a SPECT study (Riba et al., 2006).”
BackgroundMengod, G., Pompeiano, M., ́nez-Mir, M. I. M., & Palacios, J. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90502-3 · Cited by 240 · cited 1×
“The 5-HT2A receptor is expressed heavily in the PFC and adjacent cortical regions, particularly in lamina V (Mengod et al., 1990; LopezGimenez et al., 1997; Jakab and Goldman-Rakic, 1998; Cornea-Hébert et al., 1999).”
BackgroundQuednow, B. B., Kometer, M., Geyer, M. A., & Vollenweider, F. X. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.228 · Cited by 240 · cited 8×
“…measures in humans, including tests of spatial working memory (Vollenweider et al., 1998), prepulse inhibition of acoustic startle (Quednow et al., 2012), N170 visual-evoked potentials (Kometer et al., 2013), semantic interference in the Stroop test (Quednow et al., 2012), and…”
BackgroundMethodInfluentialPsychedelic Drugs Reconsidered
Grinspoon, L., & Bakalar, J. B. (1979) · Medical Entomology and Zoology · Cited by 239
Activation of Serotonin Receptors Modulates Synaptic Transmission in Rat Cerebral Cortex
Zhou, F.-M., & Hablitz, J. J. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.2989 · Cited by 238 · cited 2×
“5-HT2A receptor activation also increases the frequency of spontaneous IPSCs in pyramidal neurons (Zhou and Hablitz, 1999), an effect that is mediated by activation of neighboring GABAergic interneurons (Weber and Andrade, 2010; Zhang et al., 2010).”
BackgroundCarhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237 · cited 2×
“Likewise, hallucinogens enhance memory recall (Carhart-Harris et al., 2012b), sometimes producing extremely vivid recollections.”
BackgroundCarter, O. L., Burr, D. C., Pettigrew, J. D., Wallis, G. M., Hasler, F., & Vollenweider, F. X. (2005) · Journal of Cognitive Neuroscience · doi:10.1162/089892905774597191 · Cited by 234 · cited 1×
“…on the OB, AED, and VR dimensions of the APZOAV and 5D-ASC are completely blocked by pretreatment with either the 5-HT2A/2C antagonist ketanserin or the mixed 5-HT2A/D2 antagonist risperidone (Vollenweider et al., 1998; Carter et al., 2005, 2007; Kometer et al., 2012, 2013; Quednow et al., 2012).”
BackgroundAgonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 231 · cited 1×
“Schmid and colleagues have reported that β-arrestin-2 is not required for the behavioral effects of DOI and 5-MeO-DMT (Schmid et al., 2008; Schmid and Bohn, 2010).”
BackgroundA potent excitatory input to the nucleus locus coeruleus from the ventrolateral medulla
Ennis, M. J., & Aston‐Jones, G. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90637-3 · Cited by 231 · cited 2×
“Although the nucleus paragigantocellularis in the ventrolateral rostral medulla is a major source of excitatory input into the LC (Ennis and Aston-Jones, 1986; Chiang and Aston-Jones, 1993), the ability of somatosensory stimuli to excite the LC is unaffected by lesions of nucleus…”
BackgroundVarty, G. B., Higgins, G. A., & Higgins, G. A. (1995) · Psychopharmacology · doi:10.1007/bf02246437 · Cited by 231 · cited 1×
“Although one study found haloperidol can block the PPI disruption produced by hallucinogens (Sipes and Geyer, 1994), this was not replicated by subsequent investigations (Varty and Higgins, 1995; Behav Brain Res.”
ResultPuig, M. V., Celada, P., Díaz‐Mataix, L., & Artigas, F. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.8.870 · Cited by 229 · cited 5×
“…have shown that DOI (0.05–0.8 mg/kg, i.v.) and 5-MeO-DMT (0.1 mg/kg, i.v., in combination with the monoamine oxidase inhibitor clorgyline) produce a net excitatory effect on pyramidal neurons in the PrL, IL, and ACA regions of mPFC (Puig et al., 2003; Wang et al., 2009; Riga et al., 2014).”
BackgroundResultInfluentialBéïque, J.-C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700436104 · Cited by 229 · cited 4×
“…5-HT2A-induced sEPSCs in layer V pyramidal neurons 1 DOI-induced head twitch response 1 5-HT2A antagonist ↓ M100907 Aghajanian & Marek, 1997 Beique et al., 2007 Benneyworth et al., 2007 ↓ M100907 Schreiber et al., 1995 5-HT2C antagonist Ø SB242084 Marek & Aghajanian, 1999 Beique et al.,…”
BackgroundInfluentialCharacterization of the head-twitch response induced by hallucinogens in mice
Halberstadt, A. L., & Geyer, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3006-z · Cited by 228 · cited 3×
“The kinematics of the HTR induced by DOI have been characterized in C57BL/6J mice and Sprague-Dawley rats (Halberstadt and Geyer, 2013).”
BackgroundMethodSelf-citationInfralimbic cortex activation increases c-fos expression in intercalated neurons of the amygdala
Berretta, S., Pantazopoulos, H., Caldera, M., Pantazopoulos, P., & Paré, D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.020 · Cited by 223 · cited 2×
“…mPFC inhibits the amygdala because the projection is glutamatergic (Amaral and Insausti, 1992; Smith et al., 2000), the mechanism is now believed to involve excitation of GABAergic neurons in the intercalated nuclei of the amygdala (Berretta et al., 2005; Likhtik et al., 2008; Pinard et al., 2012).”
BackgroundShulgin, A. T., & Shulgin, A. (1997) · Cited by 223
Marek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221 · cited 3×
“Receptor Ligand pharmacology 5-HT2A-induced sEPSCs in layer V pyramidal neurons 1 DOI-induced head twitch response 1 5-HT2A antagonist ↓ M100907 Aghajanian & Marek, 1997 Beique et al., 2007 Benneyworth et al., 2007 ↓ M100907 Schreiber et al., 1995 5-HT2C antagonist Ø SB242084 Marek & Aghajanian, 1999 Beique et al., 20…”
BackgroundGouzoulis-Mayfrank, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00089-x · Cited by 219 · cited 2×
“…et al., 1994) Double-blind studies have confirmed the APZ and the HRS can distinguish the effects of psilocybin and mescaline from those of (+)-methamphetamine, methylphenidate, and 3,4-methylenedioxyethylamphetamine (Hermle et al., 1992; Gouzoulis-Mayfrank et al., 1999b; Griffiths et al., 2006).”
BackgroundInfluentialBraden, M. R., Parrish, J. C., Naylor, J. C., & Nichols, D. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028720 · Cited by 217 · cited 2×
“Although N-alkyl substituted phenylalkylamines are usually inactive as hallucinogens, the addition of a N-benzyl group to phenethylamines can dramatically increase their activity, and N-benzylphenethylamines are a new class of potent hallucinogenic compounds (Braden et al., 2006).”
BackgroundMultivariate assessment of locomotor behavior: Pharmacological and behavioral analyses
Geyer, M. A., Russo, P. V., & Masten, V. L. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90266-2 · Cited by 215 · cited 2×
“One example is the Behavioral Pattern Monitor (BPM), which combines features from activity chambers and holeboards and provides quantitative as well as qualitative measures of the spatial and temporal structure of activity (Geyer et al., 1986; Paulus and Geyer, 1991).”
BackgroundMethodHalberstadt, A. L., Koedood, L., Powell, S. B., & Geyer, M. A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110388326 · Cited by 213 · cited 5×
“…twitches in response to mescaline, DOI, DOM, LSD, DMT, 5-MeO-DMT, psilocin, or 1-methylpsilocin (González-Maeso et al., 2007; Keiser et al., 2009; Halberstadt et al., 2011), although the response can be rescued by selectively restoring the 5-HT2A receptor gene to cortical regions (González-Maeso…”
BackgroundInfluentialSelf-citationPuig, M. V., Watakabe, A., Ushimaru, M., Yamamori, T., & Kawaguchi, Y. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3335-09.2010 · Cited by 205 · cited 1×
“In addition to pyramidal neurons, 5-HT2A receptors are also expressed by subsets of parvalbumin- and calbindin-positive interneurons (Willins et al., 1997; Jakab and Goldman-Rakic, 2000; Santana et al., 2004; De Almeida and Mengod, 2007; Puig et al., 2010; Weber and Adrade, 2010).”
BackgroundWeber (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00036 · Cited by 205
Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907
López‐Giménez, J. F., Mengod, G., Palacios, J. M., & Vilaró, M. T. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005075 · Cited by 203
Liang, F., Hatanaka, Y., Saito, H., Yamamori, T., & Hashikawa, T. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000124)416:4 · Cited by 202
Release of neurotransmitters in the locus coeruleus
Singewald, N. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00039-2 · Cited by 197 · cited 1×
“…in the dorsal pons, is the source of almost all noradrenergic projections in the CNS. LC neurons are responsive to sensory stimuli, especially of a novel or arousing nature, and the firing of LC neurons is markedly increased by noxious stimulation (reviewed by: Singewald and Philippu, 1998).”
BackgroundDifferential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
McKenna, D. J., Repke, D. B., Lo, L., & Peroutka, S. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90001-8 · Cited by 195 · cited 1×
“Indoleamine and phenylalkylamine hallucinogens bind to 5-HT2 sites with moderate to high affinity (Shannon et al., 1984; Lyon et al., 1988; Sadzot et al., 1989; McKenna et al., 1990).”
BackgroundCellular localization of serotonin2A (5HT2A) receptors in the rat brain
Xu, T., & Pandey, S. C. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00278-6 · Cited by 194 · cited 1×
“Almost all prefrontal pyramidal neurons express the 5-HT2A receptor, with the receptor localized primarily to the proximal apical dendrites (Willins et al., 1997; Jakab and Goldman-Rakic, 1998; Cornea-Hébert et al., 1999; Xu and Pandey, 2000).”
BackgroundGouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Obradovic, M., & Kovar, K. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-916185 · Cited by 194 · cited 2×
“…study comparing DMT and the NMDA antagonist (S)-ketamine found DMT produces effects that more closely resemble the positive symptoms of schizophrenia, whereas the effects of (S)-ketamine are more similar to the negative and catatonic symptoms of schizophrenia (Gouzoulis-Mayfrank et al., 2005).”
BackgroundCallaway, C. W., Wing, L., & Geyer, M. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12637-2 · Cited by 192 · cited 1×
“Extensive testing has confirmed this pattern of effects in the BPM is highly specific to hallucinogens (Geyer et al., 1986, 1987; Mittman and Geyer, 1989; Callaway et al., 1990; Lehmann-Masten and Geyer, 1991).”
BackgroundGlennon, R. A., Young, R., & Rosecrans, J. A. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90464-8 · Cited by 190 · cited 3×
“…and all legal disclaimers that apply to the journal pertain. anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript hallucinogens produce similar discriminative stimulus effects (Glennon et al., 1982) and act as agonists of the serotonin-2A (5-HT2A) receptor (Glennon et al., 1983).”
BackgroundActions of 5-hydroxytryptamine on neurons of the rat cingulate cortex
Tanaka, E., & North, R. A. (1993) · Journal of Neurophysiology · doi:10.1152/jn.1993.69.5.1749 · Cited by 190 · cited 1×
“…neurons: there is a moderate depolarization, spike-frequency accommodation is reduced, and the afterhyperpolarization (AHP) that normally follows a burst of spikes is replaced by a slow depolarizing afterpotential (sADP)(Araneda and Andrade, 1991; Tanaka and North, 1993; Arvanov et al., 1999).”
BackgroundJakab, R., & Goldman-Rakic, P. (2000) · The Journal of comparative neurology · doi:10.1002/(sici)1096-9861(20000214)417:3 · Cited by 188
Retrograde transport of D-[3H]-aspartate injected into the monkey amygdaloid complex
Amaral, D. G., & Insausti, R. (1992) · Experimental Brain Research · doi:10.1007/bf02259113 · Cited by 187 · cited 1×
“Although it was not initially clear how mPFC inhibits the amygdala because the projection is glutamatergic (Amaral and Insausti, 1992; Smith et al., 2000), the mechanism is now believed to involve excitation of GABAergic neurons in the intercalated nuclei of the amygdala (Berretta et al., 2005;…”
BackgroundHallucinations. Behavior, Experience, and Theory.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-4-511_2 · Cited by 185
Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats
Sipes, T. E., & Geyer, M. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90074-4 · Cited by 184 · cited 3×
“Although one study found haloperidol can block the PPI disruption produced by hallucinogens (Sipes and Geyer, 1994), this was not replicated by subsequent investigations (Varty and Higgins, 1995; Behav Brain Res.”
BackgroundMethodResultHermle, L., Fünfgeld, M., Oepen, G., Botsch, H., Borchardt, D., Gouzoulis, E., Fehrenbach, R. A., & Spitzer, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90059-9 · Cited by 183 · cited 6×
“) produces a hyperfrontal metabolic pattern, especially in the right hemisphere (Hermle et al., 1992).”
BackgroundInfluentialSchmid, C. L., & Bohn, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1665-10.2010 · Cited by 181 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and p38 MAP kinase), Akt, and phospholipase D (dependent on the small G protein ADPribosylation factor-1 (ARF1)) (Kurrasch-Orbaugh et al., 2003a; González-Maeso et al., 2007; Schmid and Bohn, 2010; Barclay et al., 2011).”
BackgroundIn vivoproperties of SB 200646A, a 5‐HT2C/2Breceptor antagonist
Kennett, G. A., Wood, M. D., Glen, A., Grewal, S., Forbes, I., Gadre, A., & Blackburn, T. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14808.x · Cited by 181 · cited 2×
“Similarly, there is a consensus in the literature that the ability of DOI to induce the HTR is not blocked by selective 5-HT2C antagonists or mixed 5-HT2C/2B antagonists (Kennett et al., 1994; Schreiber et al., 1995; Wettstein et al., 1999; Vickers et al., 2001; Fantegrossi et al., 2010).”
BackgroundGABA-mediated inhibition of locus coeruleus from the dorsomedial rostral medulla
Ennis, M. J., & Aston‐Jones, G. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-08-02973.1989 · Cited by 180 · cited 1×
“It is likely that the nucleus prepositus hypoglossi (PrH), an area known to provide direct GABAergic inhibitory input into the LC (Ennis and Aston-Jones, 1989a,b), mediates the hallucinogen-induced inhibition of spontaneous LC activity.”
Background5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice
Halberstadt, A. L., van der Heijden, I., Ruderman, M. A., Risbrough, V. B., Gingrich, J. A., Geyer, M. A., & Powell, S. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.29 · Cited by 179 · cited 1×
“Phenylalkylamines, including DOI, mescaline, and TCB-2, inhibit investigatory behavior and alter locomotor activity in a dose-dependent manner, increasing activity at low to moderate doses and reducing activity at high doses (Halberstadt et al., 2009, 2013).”
BackgroundSelf-citationHaertzen, C. A., Hill, H. E., & Belleville, R. E. (1963) · Psychopharmacology · doi:10.1007/bf02584088 · Cited by 172 · cited 2×
“Studies using the Addiction Research Center Inventory (ARCI) instrument (Haertzen et al., 1963) have confirmed that the effects of LSD are dissimilar from those of (+)-amphetamine (Rosenberg et al., 1963) and Δ9tetrahydrocannabinol (Isbell and Jasinski, 1969).”
MethodColpaert, F. C., Niemegeers, C. J. E., & Janssen, P. A. J. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33038-7 · Cited by 168 · cited 1×
“The stimulus effects of hallucinogens can be blocked by the selective 5-HT2 antagonists ketanserin and pirenperone (Colpaert et al., 1982; Glennon et al., 1983; Glennon, 1986; Cunningham and Appel, 1987; Appel and Callahan, 1989).”
BackgroundPiercey, M. F., Hoffmann, W. E., Smith, M., & Hyslop, D. K. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00454-2 · Cited by 167
Zhang, G., Ásgeirsdóttir, H. N., Cohen, S. J., Munchow, A. H., Barrera, M. P., & Stackman, R. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.007 · Cited by 167 · cited 1×
“Psilocybin and TCB-2 have been shown to facilitate the extinction of fear conditioning in C57BL/6J mice (Catlow et al., 2013; Zhang et al., 2013), which could be a consequence of activating the projection from IL to the intercalated nuclei.”
BackgroundCarr, D. B., Cooper, D., Ulrich, S., Spruston, N., & Surmeier, D. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06846.2002 · Cited by 166 · cited 2×
“respectively, effects that would likely influence dendritic integration (Carr et al., 2002; Day et al., 2002).”
BackgroundKurrasch‐Orbaugh, D. M., Watts, V. J., Barker, E. L., & Nichols, D. E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042184 · Cited by 166 · cited 4×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and p38 MAP kinase), Akt, and phospholipase D (dependent on the small G protein ADPribosylation factor-1 (ARF1)) (Kurrasch-Orbaugh et al., 2003a; González-Maeso et al., 2007; Schmid and Bohn, 2010; Barclay et al., 2011).”
BackgroundInfluentialBennett, J. P., & Snyder, S. H. (1975) · Brain Research · doi:10.1016/0006-8993(75)90234-6 · Cited by 165
Gewirtz, J. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00136-6 · Cited by 164 · cited 2×
“…Marek et al., 2000 Klodzinska et al., 2002 ↓ LY354740 Gewirtz and Marek, 2000 Klodzinska et al., 2002) ↓ LY379268 Klodzinska et al., 2002 antagonist ↑ LY341495 Marek et al., 2000 ↓ LY341495 Gewirtz and Marek, 2000 Adenosine A1 agonist ↓ N6-cyclopentyladenosine Stutzmann et al., 2001 ↓…”
Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats
Geyer, M. A., Russo, P. V., Segal, D. S., & Kuczenski, R. T. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90460-6 · Cited by 161 · cited 1×
“Extensive testing has confirmed this pattern of effects in the BPM is highly specific to hallucinogens (Geyer et al., 1986, 1987; Mittman and Geyer, 1989; Callaway et al., 1990; Lehmann-Masten and Geyer, 1991).”
BackgroundVisual disturbances after prolonged perceptual isolation.
Heron, W., Doane, B., & Scott, T. H. (1956) · Canadian Journal of Psychology/Revue Canadienne de Psychologie · doi:10.1037/h0083650 · Cited by 161 · cited 2×
“…and can occur during a variety of hallucinatory states, including migraine aura (Sacks, 1995), epilepsy (Horowitz et al., 1967), sensory isolation (Heron et al., 1956), viewing flickering light (Becker and Elliott, 2006; Allefeld et al., 2011), and electrical cortical stimulation (Knoll et al.,…”
BackgroundPrefrontal neurons transmit signals to parietal neurons that reflect executive control of cognition
Crowe, D. A., Goodwin, S. J., Blackman, R. K., Sakellaridi, S., Sponheim, S. R., MacDonald, A. W., & Chafee, M. V. (2013) · Nature Neuroscience · doi:10.1038/nn.3509 · Cited by 160
Vollenweider, F., Csomor, P., Knappe, B., Geyer, M., & Quednow, B. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301324 · Cited by 159 · cited 1×
“…of hallucinogens is admittedly speculative, it does receive some support from the fact that hallucinogens disrupt PPI in humans and in animal models (Sipes and Geyer, 1994; Padich et al., 1996; Vollenweider et al., 2007; Pálenícek et al., 2008; Halberstadt and Geyer, 2010; Quednow et al., 2012).”
BackgroundBenneyworth, M. A., Xiang, Z., Smith, R. L., Garcia, E. E., Conn, P. J., & Sanders‐Bush, E. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035170 · Cited by 159 · cited 8×
“Receptor Ligand pharmacology 5-HT2A-induced sEPSCs in layer V pyramidal neurons 1 DOI-induced head twitch response 1 5-HT2A antagonist ↓ M100907 Aghajanian & Marek, 1997 Beique et al., 2007 Benneyworth et al., 2007 ↓ M100907 Schreiber et al., 1995 5-HT2C antagonist Ø SB242084 Marek & Aghajanian, 1999 Beique et al., 20…”
BackgroundInfluential5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex
Abi‐Saab, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00046-3 · Cited by 158 · cited 16×
“Chiang and Aston-Jones (1993) reported that the decrease in LC spontaneous firing induced by DOI could be blocked by the GABAA receptor antagonists bicuculline and picrotoxin, whereas the ability of DOI to enhance sensory-evoked LC responses was blocked by the NMDA receptor antagonist 2-amino-5-phosphonopentanoic acid…”
ResultInfluentialMarek, G. J., Wright, R. A., Gewirtz, J. C., & Schoepp, D. D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00199-3 · Cited by 158 · cited 1×
“…any glutamatergic mPFC neurons that were driven to fire action potentials by 5-HT2A activation, it was initially thought that the increase in Glu release was caused by local activation of the terminals of glutamatergic thalamocortical afferents (Lambe and Aghajanian, 2001; Marek et al., 2001).”
BackgroundScruggs, J. L., Patel, S., Bubser, M., & Deutch, A. Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08846.2000 · Cited by 154 · cited 15×
“…mGlu2/3 agonists and AMPA antagonists also block the ability of DOI to increase cortical expression of BDNF and the immediate-early genes c-fos, erg-2, and Arc (Scruggs et al., 2000; Gewirtz et al., 2002; Zhai et al., 2003; Pei et al., 2004; GonzalezMaseo et al., 2008; Wischhof and Koch, 2012).”
BackgroundInfluentialHuot, P., Johnston, T. H., Darr, T., Hazrati, L., Visanji, N. P., Pires, D., Brotchie, J. M., & Fox, S. H. (2010) · Movement Disorders · doi:10.1002/mds.23083 · Cited by 153 · cited 3×
“According to another study conducted post-mortem, Parkinson's patients with visual hallucinations show elevated levels of 5-HT2A binding in the inferolateral temporal cortex (BA 21) (Huot et al., 2010).”
BackgroundHallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex
Pierce, P. A., & Peroutka, S. J. (1989) · Psychopharmacology · doi:10.1007/bf00443425 · Cited by 152 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Phenylalkylamine hallucinogens are selective for 5-HT2 receptors, including 5-HT2A, 5- HT2B, and 5-HT2C sites (Titeler et al., 1988; Leysen, 1989; Pierce and Peroutka, 1989).”
BackgroundWood, J. T., Kim, Y., & Moghaddam, B. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6377-11.2012 · Cited by 152 · cited 5×
“In contrast to those findings, another group has reported that higher doses of DOI (3–5 mg/kg, i.p.) tend to inhibit the firing of pyramidal cells in ACA and the ventral, dorsolateral, and lateral orbitofrontal cortices of behaving rats (Wood et al., 2012).”
BackgroundResultInfluentialMismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
Heekeren, K., Daumann, J., Neukirch, A., Stock, C., Kawohl, W., Norra, C., Waberski, T. D., & Gouzoulis‐Mayfrank, E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1129-4 · Cited by 152
Johansson, C., Jackson, D. M., Zhang, J., & Svensson, L. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00160-x · Cited by 148 · cited 11×
“The phenylalkylamines can be subdivided into phenethylamines, such as mescaline from the peyote cactus (Lophophora williamsii), 2,5-dimethoxy-4-bromophenethylamine (2C-B), and 2,5-dimethoxy-4-iodophenethylamine (2C-I); and phenylisopropylamines (“amphetamines”), including DOM, 2,5-dimethoxy-4-iodoamphetamine (DOI), an…”
MethodInfluentialAgonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors
Smith, R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00110-5 · Cited by 147 · cited 5×
“…a 5-HT2A antagonist with high selectivity versus the 5-HT2C receptor, blocks stimulus control in animals trained with DOI (Schreiber et al., 1994; Smith et al., 1998, 1999, 2003), DOM (Li et al., 2008; May et al., 2009), R-(–)- DOM (Eckler et al., 2003), LSD (Winter et al., 2004; Benneyworth et…”
BackgroundInfluentialSzabo, S. T., & Blier, P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03121-3 · Cited by 146 · cited 1×
“Furthermore, Szabo and Blier (2001) found that the ability of DOI to alter the activity of LC neurons is abolished by M100907.”
BackgroundPsilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans
Carter, O. L., Hasler, F., Pettigrew, J. D., Wallis, G. M., Liu, G. B., & Vollenweider, F. X. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0930-9 · Cited by 146 · cited 1×
“…on the OB, AED, and VR dimensions of the APZOAV and 5D-ASC are completely blocked by pretreatment with either the 5-HT2A/2C antagonist ketanserin or the mixed 5-HT2A/D2 antagonist risperidone (Vollenweider et al., 1998; Carter et al., 2005, 2007; Kometer et al., 2012, 2013; Quednow et al., 2012).”
BackgroundGouzoulis‐Mayfrank, E., Thelen, B., Habermeyer, E., Kunert, H. J., Kovar, K. ‐., Lindenblatt, H., Hermle, L., Spitzer, M., & Sass, H. (1999) · Psychopharmacology · doi:10.1007/s002130050860 · Cited by 145 · cited 2×
“…et al., 1994) Double-blind studies have confirmed the APZ and the HRS can distinguish the effects of psilocybin and mescaline from those of (+)-methamphetamine, methylphenidate, and 3,4-methylenedioxyethylamphetamine (Hermle et al., 1992; Gouzoulis-Mayfrank et al., 1999b; Griffiths et al., 2006).”
BackgroundInfluentialHallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats
Fantegrossi, W. E., Harrington, A. W., Kiessel, C. L., Eckler, J. R., Rabin, R. A., Winter, J. C., Coop, A., Rice, K. C., & Woods, J. H. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.12.015 · Cited by 145 · cited 2×
“…cues involving both 5-HT1A- and 5-HT2A-mediated components (Glennon et al., 1988; Winter et al., 2000; Fantegrossi et al., 2008), 5-HT1A receptors do not play a role in the interoceptive effects of psilocybin (Winter et al., 2007) or 5-methoxy-N,N-diisopropyltryptamine (Fantegrossi et al., 2006).”
BackgroundCozzi, N. V., Gopalakrishnan, A., Anderson, L. L., Feih, J. T., Shulgin, A. T., Daley, P. F., & Ruoho, A. E. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0308-8 · Cited by 144 · cited 3×
“However, compared with σ1 and SERT, tryptamines are more potent at 5-HT1A and 5-HT2A receptors by several orders of magnitude, so the former sites probably do not contribute to the hallucinogenic response.”
BackgroundAutonomic, Neuroendocrine, and Immunological Effects of Ayahuasca
SANTOS, R. G. D., Valle, M., Bouso, J. C., Nomdedeu, J. F., Rodrı́guez-Espinosa, J., McIlhenny, E. H., Barker, S. A., Barbanoj, M. J., & Riba, J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823607f6 · Cited by 143 · cited 2×
“Ayahuasca also elicited significantly greater effects than (+)-amphetamine on 4 of 6 subscales of the HRS (Dos Santos et al., 2011).”
BackgroundFreedman, D. X. (1968) · Archives of General Psychiatry · doi:10.1001/archpsyc.1968.01740030074008 · Cited by 143
Moreno, J. L., Muguruza, C., Umali, A., Mortillo, S., Holloway, T. D., Pilar-Cuéllar, F., Mocci, G., Seto, J., Callado, L. F., Neve, R. L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413161 · Cited by 142 · cited 2×
“Evidence has emerged that mGlu2 and 5- HT2A receptors can form heteromeric complexes in cortex (Gonzalez-Maeso et al., 2008; Moreno et al., 2012), and these complexes may mediate the crosstalk that occurs between these receptors.”
BackgroundComparison of the reactions induced by psilocybin and LSD-25 in man
Isbell, H. (1959) · Psychopharmacology · doi:10.1007/bf00408109 · Cited by 140 · cited 1×
“…having different chemical structures, phenylalkylamine, tryptamine, and ergoline hallucinogens produce remarkably similar subjective effects (Isbell, 1959; Hollister, 1961; Wolbach et al., 1962a,b; Hollister and Hartman, 1962; Rosenberg et al., 1964; Abramson and Rolo, 1967; Hollister et…”
BackgroundHallucinogens: Neurochemical, Behavioral, and Clinical Perspectives
Jenner, P. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.4.392 · Cited by 139
Psychedelic drugs and mystical experience.
Pahnke, W. N. (1969) · PubMed · Cited by 138
Kurrasch‐Orbaugh, D. M., Parrish, J. C., Watts, V. J., & Nichols, D. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01921.x · Cited by 138 · cited 4×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and p38 MAP kinase), Akt, and phospholipase D (dependent on the small G protein ADPribosylation factor-1 (ARF1)) (Kurrasch-Orbaugh et al., 2003a; González-Maeso et al., 2007; Schmid and Bohn, 2010; Barclay et al., 2011).”
BackgroundInfluentialCross tolerance between LSD and psilocybin
Isbell, H., Wolbach, A. B., Wikler, A., & Miner, E. J. (1961) · Psychopharmacologia · doi:10.1007/bf00407974 · Cited by 137 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript and there is eventually nearly a complete loss of response (Abramson et al., 1956; Isbell et al., 1956, 1961; Angrist et al., 1974).”
BackgroundFiorella, D. J., Rabin, R. A., & Winter, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246074 · Cited by 137 · cited 3×
“Although animals trained with DOM will generalize to lisuride (Glennon and Hauck 1985; Fiorella et al. 1995b), the response to DOM is attenuated when it is co-administered with lisuride (Glennon, 1991).”
BackgroundInfluentialDose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
MacLean, K. A., Johnson, M. W., Reissig, C. J., Prisinzano, T. E., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2912-9 · Cited by 136 · cited 2×
“…produced by classical hallucinogens and the κ-opioid receptor agonist salvinorin A from Salvia divinorum, there is evidence that the phenomenology of salvinorin A is unique (Albertson and Grubbs, 2009), and the ARCI is relatively insensitive to the effects of salvinorin A (MacLean et al., 2013).”
BackgroundThe Use of LSD in Psychotherapy and Alcoholism
Blaine, G. B. (1968) · Psychosomatic Medicine · doi:10.1097/00006842-196807000-00014 · Cited by 135
Riba, J., Anderer, P., Jané, F., Saletu, B., & Barbanoj, M. J. (2004) · Neuropsychobiology · doi:10.1159/000077946 · Cited by 134 · cited 1×
“Likewise, electroencephalographic studies have reported that ayahuasca (containing the equivalent of 0.85 mg/kg DMT) reduces cortical oscillatory power across multiple frequency bands (Riba et al., 2002, 2004).”
BackgroundInfluentialMarona‐Lewicka, D., Thisted, R. A., & Nichols, D. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2183-9 · Cited by 134
A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants
Paulus, M. P., & Geyer, M. A. (1991) · Psychopharmacology · doi:10.1007/bf02244547 · Cited by 134 · cited 1×
“One example is the Behavioral Pattern Monitor (BPM), which combines features from activity chambers and holeboards and provides quantitative as well as qualitative measures of the spatial and temporal structure of activity (Geyer et al., 1986; Paulus and Geyer, 1991).”
MethodThe Gamma Oscillation: Master or Slave?
Schroeder, C. E., & Lakatos, P. (2009) · Brain Topography · doi:10.1007/s10548-009-0080-y · Cited by 133 · cited 1×
“…the active waking state, which is characterized by fast rhythms in the gamma range (30–80 Hz) that play a putative role in a multitude of perceptual and cognitive functions (Tallon-Baudry et al., 1998; Fries et al., 2001; Herrmann et al., 2004; Schroeder and Lakatos, 2009; Roux and Uhlhaas, 2014).”
BackgroundCP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Siuciak, J., Chapin, D., McCarthy, S. A., Guanowsky, V., Brown, J. A., Chiang, P., Marala, R., Patterson, T., Seymour, P., Swick, A., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.024 · Cited by 132 · cited 1×
“There is also evidence that the ability of DOI to induce the HTR is significantly attenuated by pretreatment with selective 5-HT2C agonists, including Ro 60-0175, CP-809,101, and mCPP (Schreiber et al., 1995; Siuciak et al., 2007; Fantegrossi et al., 2010; Canal et al., 2013).”
Background
Flagged first, then by citations
4 of the 462 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Glennon, 1982, The use of the drug discrimination paradigm for studying hallucinogenic agents. A review, 69
- Dittrich, 1975, Zusammenstellung eines Fragebogens (APZ) zur Erfassung abnormer psychischer Zustände, Z Klin Psychol Psychother, 23, 12
- Young, 1981, The hallucinogen DOM as a discriminative stimulus, Commun Psychopharmacol, 4, 501
- Glennon, 1985, Site-selective 5-HT agonists as discriminative stimuli, Pharmacologist, 27, 194
- Serko, 1913, Im Mescalinrausch, Jahrb Psychiatr Neurol, 31, 355
- Prentiss, 1895, Anhalonium lewinii (mescal buttons): a study of the drug, with especial reference to its physiological action upon man, with report of experiments, Ther Gaz, 19, 577
- Ellis, 1898, Mescal: a new artificial paradise, Annu Rep Smithsonian Inst, 537
Cited by
Sorted by citations
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
“The classic hallucinogens, which include psilocybin (psilocin) and (+)-lysergic acid diethylamide (LSD), are a structurally diverse group of compounds that are 5-HT2A receptor agonists and produce a unique profile of changes in thoughts, perceptions, and emotions (Halberstadt, 2015; Nichols, 2016).”
BackgroundNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
“In the study byHalberstadt et al. (2011a), the response to psilocin was not affected by deletion of the 5-HT2A receptor gene.”
BackgroundMethodInfluentialNeural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859
“LSD has a high affinity for a range of different neurotransmitter receptors, but its characteristic psychological effects are thought to be mediated by serotonin 2A receptor (5-HT2AR) agonism (7).”
BackgroundSerotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“…this limitation, we also wish to emphasise that the evidence is compelling that 5-HT2AR agonism is key to psychedelics’ most characteristic effects (Halberstadt, 2015), 5-HT1AR agonism attenuates rather than augments these effects (Pokorny et al., 2016; Strassman, 1996) and more selective 5-HT2AR…”
BackgroundBogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2096 · Cited by 711
Metadata
- Authors
- Halberstadt, A. L.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Halberstadt, Adam L.
- ORCID
- Halberstadt, Adam L.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 277
- Pages
- 99-120
- ISSN
- 0166-4328 (ISSN-L)
- PMC
- PMC4642895
- OpenAlex
- W2052466574
- Semantic Scholar
- 09d1ad0158732c17a145c95ba0ac4f6ed7bdf021
- Cited by
- 312
- References
- 462
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 30 · 2023: 21 · 2022: 33 · 2021: 35 · 2020: 27 · 2019: 17 · 2018: 28 · 2017: 26 · 2016: 27 · 2015: 12
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIMH (K01 MH100644)
- NIDA (R01 DA002925)
- Brain and Behavior Research Foundation
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Keywords
- serotonergic hallucinogens, 5-HT2A receptor, lysergic acid diethylamide, psilocybin, mescaline, cross-tolerance, drug discrimination, head-twitch response, exploratory behavior, interval timing, electrophysiology
- MeSH terms
- Animals, Behavior, Animal, Brain, Exploratory Behavior, Hallucinogens, Humans, Lysergic Acid Diethylamide, Receptor, Serotonin, 5-HT2A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review